Consultants template- Sierra Leone Tuberculosis Drug Resistance Survey Coordinator

IMPORTANT NOTICE: Please note that the deadline for receipt of applications indicated above reflects your personal device's system settings.

..

%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E1.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EArea of expertise%5C:%3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-spacerun%5C:yes;%22%3E%3Cstrong%3E%26nbsp;%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;mso-margin-bottom-alt%5C:auto;mso-margin-top-alt%5C:auto;mso-outline-level%5C:2;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Ci%3E%3Cspan style=%22line-height%5C:115%;%22%3ETechnical experts%3C/span%3E%3C/i%3E%3Cspan style=%22line-height%5C:115%;%22%3E %3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:SimSun;mso-fareast-language%5C:ZH-CN;%22%3Ein Sierra Leone National Tuberculosis Drug Resistance Survey (TB DRS) 2026-2027.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E2.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EPurpose of consultancy%5C:%3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-spacerun%5C:yes;%22%3E%3Cstrong%3E%26nbsp;%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3EThe purpose of this full-time national consultancy is to provide dedicated day-to-day coordination, operational management and technical follow-up for the Sierra Leone National Tuberculosis Drug Resistance Survey (TB DRS) 2026-2027. The consultant will support the Ministry of Health, through the National Leprosy and Tuberculosis Control Program (NLTCP) and National Tuberculosis Reference Laboratory (NTRL), to implement the approved protocol and standard operating procedures consistently across all survey sites, maintain survey quality and participant protections, and ensure timely completion of enrolment, laboratory, data-management, monitoring, analysis and reporting milestones.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E3.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EBackground%26nbsp;%3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-spacerun%5C:yes;%22%3E%3Cstrong%3E%26nbsp;%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3ESierra Leone is preparing a cross-sectional, nationally representative, health-facility cluster-based TB drug resistance survey to estimate the prevalence and patterns of resistance to first- and second-line anti-tuberculosis medicines among bacteriologically confirmed pulmonary TB patients. The TB DRS protocol provides for 40 survey clusters nationwide, comprising 19 GeneXpert sites and 21 additional sites selected through probability-proportional-to-size sampling, with an operational target of approximately 1,400 new cases and enrolment of all eligible previously treated cases presenting at participating sites during the intake period.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3ETB Drug Resistance Survey implementation will involve consecutive patient screening and enrolment, informed consent/assent, barcode-based unique survey identification, collection and cold-chain referral of sputum specimens, testing at the NTRL, referral of selected isolates or DNA to the Supranational Reference Laboratory, data capture and validation, supportive supervision, quality assurance, analysis and dissemination. WHO guidance emphasizes that the person supervising and coordinating day-to-day survey activities should not have concurrent responsibilities outside the survey. A dedicated national coordinator is therefore required to keep the multi-institutional workflow on schedule, maintain traceability and quality, and promptly resolve operational risks.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E4.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EOverall objective%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3ETo ensure effective, timely, ethical and quality-assured coordination of the Sierra Leone TB DRS from survey readiness and launch through enrolment, laboratory and data completion, database lock, analysis, report preparation and dissemination.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E5.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ESpecific objectives%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate implementation of the approved TB DRS protocol, implementation SOPs, monitoring plan, quality plan, data management plan and related controlled survey documents.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEnsure that participating sites, the sample referral system, NTRL, data management unit and collaborating reference laboratory operate as an integrated, traceable survey system.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EMonitor enrolment, specimen movement, laboratory testing, data completeness, result return and linkage to appropriate care against approved targets and timelines.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate timely identification, documentation, escalation and closure of protocol deviations, operational bottlenecks, quality incidents and corrective and preventive actions (CAPA).%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ESupport generation of a complete, validated and analysis-ready dataset%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EContribute to preparation, review and dissemination of the final TB DRS report and associated products.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l8 level1 lfo3;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EStrengthen national capacity for drug-resistance surveillance, survey management and transition toward sustainable continuous surveillance.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E6.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EScope of work and key responsibilities%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ESurvey governance, planning and coordination%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l5 level1 lfo4;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EServe as the central operational focal point for the TB DRS and maintain the integrated implementation workplan, milestone tracker, issue log, risk register and decision log.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l5 level1 lfo4;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate routine communication among WCO Sierra Leone, NLTCP, NTRL, the Principal Investigator, the DRS Technical Working Group, district teams, participating facilities, sample referral services, SRL and other authorized partners.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l5 level1 lfo4;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EPrepare agendas, technical updates, action trackers and minutes for coordination and TWG meetings, and follow up assigned actions to closure.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l5 level1 lfo4;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEnsure use of current, approved and version-controlled protocol, SOPs, forms, tools and training materials at every implementation level.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l5 level1 lfo4;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EMaintain the survey delegation and contact lists, and ensure that role changes, staff turnover and replacement arrangements are documented and addressed.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EReadiness, training and site activation%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l13 level1 lfo5;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate pre-survey readiness assessments at participating health facilities, NTRL, the data management unit and the sample referral system using approved checklists.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l13 level1 lfo5;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EConsolidate readiness gaps, assign corrective actions, track completion and support documented go/no-go decisions before site activation.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l13 level1 lfo5;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate initial and refresher training on eligibility, consent/assent, treatment-history classification, USIN/barcoding, data tools, sputum collection, cold chain, packaging, chain of custody, laboratory workflow, confidentiality, biosafety and incident reporting.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l13 level1 lfo5;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEnsure training attendance, competency assessment, authorization and delegation records are complete before personnel undertake survey duties.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l13 level1 lfo5;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate and document any pilot or phased launch and ensure lessons are incorporated before full implementation.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EField implementation and enrolment oversight%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l4 level1 lfo6;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EMonitor consecutive screening, eligibility assessment, informed consent/assent and enrolment across all clusters, with routine reconciliation against TB and laboratory registers.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l4 level1 lfo6;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ETrack site-specific enrolment against approved targets and expected caseload, identify missed or selective enrolment, and coordinate corrective support.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l4 level1 lfo6;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEnsure consistent application of case definitions and treatment-history classification, including re-interview and source-record checks where required.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l4 level1 lfo6;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate availability and distribution of approved forms, barcode packets, specimen containers, personal protective equipment, packaging materials and other field supplies.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l4 level1 lfo6;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EProvide day-to-day troubleshooting to district and facility focal persons and escalate issues that may affect participant rights, safety, representativeness or data validity.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ESpecimen referral and laboratory coordination%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l1 level1 lfo7;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate the specimen referral schedule from participating sites to NTRL and monitor shipment completeness, cold-chain conditions, transport time, chain of custody and receipt reconciliation.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l1 level1 lfo7;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EWork with the NTRL Team Lead to monitor specimen acceptance, accessioning, molecular testing, culture, identification, phenotypic DST, isolate/DNA storage, discordance resolution and shipment to the SRL in accordance with approved procedures.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l1 level1 lfo7;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EMonitor laboratory turnaround times, invalid/indeterminate results, contamination, stock levels, equipment downtime, quality-control results and EQA actions.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l1 level1 lfo7;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEnsure critical and clinically relevant drug-resistance results are authorized, securely returned to the originating facility, acknowledged, linked to the correct participant and acted upon without avoidable delay.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l1 level1 lfo7;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate documentation and follow-up of laboratory exceptions, repeat testing, tie-breaker testing and CAPA.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EData management, monitoring and quality assurance%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate complete and timely transfer of clinical, enrolment, transport, laboratory, SRL and result-action data into the approved survey database.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EWork with the Data Manager to conduct routine range, consistency, duplicate, missingness and cross-system reconciliation checks and ensure all queries have documented resolution.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EProduce and review weekly, biweekly and monthly survey quality and progress dashboards, disaggregated by site and patient treatment history where applicable.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate remote monitoring and on-site supportive supervision according to the approved monitoring plan, with risk-based additional visits to underperforming sites.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EMaintain incident, deviation and CAPA logs and ensure serious ethical, confidentiality, biosafety or data-integrity concerns are escalated to the Principal Investigator, WCO Sierra Leone and relevant oversight bodies.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l9 level1 lfo8;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EProtect confidentiality by ensuring that identifiers are restricted to authorized linkage records and that survey data and specimens are handled according to approved access controls.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;margin-left%5C:72.0pt;mso-list%5C:l3 level1 lfo10;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Wingdings;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3Eü%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Wingdings;mso-bidi-font-weight%5C:bold;mso-fareast-font-family%5C:Wingdings;mso-list%5C:Ignore;%22%3E%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EAnalysis, reporting, dissemination and close-out%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate preparation of the participant flow diagram, site enrolment tables, missing-data summaries, quality indicators and laboratory concordance outputs required for analysis.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ESupport the epidemiologist/statistician and Data Manager to finalize the clean analytical dataset, sampling documentation, data dictionary, query log and database-lock package.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EContribute to interpretation of findings, preparation of the draft and final survey reports, technical briefs, presentations and dissemination materials.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate technical review of outputs by NLTCP, NTRL, WCO Sierra Leone, the TWG, SRL and other authorized reviewers and maintain a response-to-comments tracker.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ECoordinate survey close-out, including participant and specimen accountability, late-result follow-up, document and supply reconciliation, archiving and lessons learned.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l6 level1 lfo9;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EPrepare a practical transition plan for sustaining strengthened TB drug-resistance surveillance functions after the survey.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E7.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EDeliverables and indicative schedule%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3EThe consultant will submit concise, evidence-based deliverables to the WHO supervisor. The schedule will be aligned to the confirmed contract start date and the approved survey workplan. Months 7 and 8 apply only if the consultancy is extended beyond the initial six months.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;text-indent%5C:36.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Ci%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:SimSun;mso-fareast-language%5C:ZH-CN;%22%3E%3Cstrong%3EMonth 1%5C:%3C/strong%3E %3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/i%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3EInception report; validated implementation workplan and milestone tracker; updated governance/contact/delegation arrangements; consolidated readiness and risk assessment; site activation and training plan.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E Approved inception package; action tracker; readiness dashboard; meeting records.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Ci%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EMONTH 2%5C: %3C/strong%3E%3C/span%3E%3C/i%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3ESurvey launch/implementation coordination report; training and competency completion summary; site activation status; initial enrolment, specimen referral, laboratory and data-quality dashboard.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E %3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EVerified training/activation records; first monthly dashboard; documented closure/escalation of start-up issues.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EMONTH 3%5C: %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EField and laboratory performance report; enrolment and sample-flow analysis by cluster; monitoring visit reports; updated risk, incident and CAPA logs; supply and equipment status.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E %3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EMonthly report accepted; monitoring evidence; CAPA owners and due dates assigned.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EMONTH 4%5C: %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EMid-implementation review package; consolidated quality and progress indicators; laboratory TAT and result-return analysis; data reconciliation report; corrective implementation plan.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E Midterm presentation/report; endorsed corrective plan; updated milestone tracker.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EMONTH 5%5C: %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EImplementation completion/acceleration report; cluster target and missed-enrolment review; specimen and testing backlog plan; data-query closure dashboard; SRL shipment/reconciliation status.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E Documented backlog reduction plan; current specimen/data accountability; monthly report accepted.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EMONTH 6%5C: %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EKey Deliverables%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3EEnd-of-initial-contract report; comprehensive implementation status; preliminary close-out and database-lock plan; draft participant flow and analytical tables; handover package or extension workplan.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%3Cstrong%3EAcceptence Evidence%5C:%3C/strong%3E Accepted six-month report; validated handover/extension plan; documented outstanding actions.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Calibri;mso-fareast-language%5C:EN-US;mso-fareast-theme-font%5C:minor-latin;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E8.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EPerformance monitoring and acceptance criteria%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EDeliverables are submitted in the agreed format and are technically accurate, complete, traceable to source records and suitable for decision-making.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3ESurvey milestones and action items are actively tracked, with delays and risks escalated early and accompanied by feasible mitigation measures.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EQuality and progress reports cover enrolment, data completeness, sample transport, laboratory processing, test outcomes, result return, deviations and CAPA.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EAll recommendations respect the approved protocol, ethics requirements, confidentiality safeguards, biosafety procedures and WHO technical guidance.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EDocuments use controlled versions, consistent identifiers and clear audit trails. No unsupported alteration of source data or laboratory results is permitted.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l7 level1 lfo11;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EPerformance will be reviewed by the WHO supervisor in consultation with designated NLTCP/NTRL counterparts and the DRS governance structures.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E9.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EReporting and working arrangements%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l14 level1 lfo12;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EThe consultant will be based full-time at WCO Sierra Leone and will work closely with NLTCP and NTRL. Regular physical presence at implementation sites may be required.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l14 level1 lfo12;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EThe consultant will report technically and administratively to the WHO supervisor designated in the contract. Day-to-day coordination will be undertaken in close collaboration with the NLTCP Program Manager, Principal Investigator, NTRL Team Lead and DRS TWG.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l14 level1 lfo12;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EThe consultant will provide brief weekly implementation updates, a structured monthly report, immediate alerts for critical incidents, and presentations for scheduled governance meetings.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l14 level1 lfo12;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EAll official communication, data access, document sharing and external engagement must follow WHO and national authorization pathways.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l14 level1 lfo12;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EThe consultant will not independently release survey findings or participant-level information and will not represent WHO or the Government beyond the authority explicitly provided in the contract.%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E10.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-spacerun%5C:yes;%22%3E%3Cstrong%3E %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ERequired qualifications and experience%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22color%5C:#17365D;font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight%5C:normal;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EEducation%3C/strong%3E%3C/span%3E%3C/b%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l10 level1 lfo13;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EEssential%5C: Advanced university degree in medicine, public health, epidemiology, microbiology, laboratory sciences, biostatistics, health program management or another field directly relevant to tuberculosis surveillance and survey implementation.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l10 level1 lfo13;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EDesirable%5C: Additional postgraduate training in epidemiology, implementation research, project management, monitoring and evaluation, data management, laboratory quality management or tuberculosis control.%3C/span%3E%3C/p%3E%3Cp class=%22MsoNormal%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22color%5C:#17365D;font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight%5C:normal;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3EExperience%3C/strong%3E%3C/span%3E%3C/b%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpFirst%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l11 level1 lfo14;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EAt least seven years of progressively responsible professional experience in public health program implementation, disease surveillance, operational research or survey coordination, including substantial experience in tuberculosis.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l11 level1 lfo14;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EDemonstrated experience coordinating a national or multi-site health survey, research study, surveillance activity or similarly complex public-health project.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l11 level1 lfo14;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EExperience working with a national TB program, reference laboratory, district health teams and health facilities in Sierra Leone or a comparable setting.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l11 level1 lfo14;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EPractical experience in at least three of the following areas%5C: field enrolment and monitoring; specimen referral; TB laboratory workflows and quality assurance; data management and validation; ethics and consent; risk/incident/CAPA management; analysis and technical report writing.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpMiddle%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l11 level1 lfo14;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EExperience facilitating multidisciplinary technical working groups, training, supportive supervision and stakeholder review processes.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBulletCxSpLast%22 style=%22line-height%5C:115%;margin-bottom%5C:2.0pt;mso-add-space%5C:auto;mso-list%5C:none;tab-stops%5C:list 18.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3E%26nbsp;%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E11.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ETravel, logistics and duty of care%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListBullet%22 style=%22line-height%5C:115%;margin%5C:0cm 0cm 2.0pt 36.0pt;mso-add-space%5C:auto;mso-list%5C:l12 level1 lfo15;tab-stops%5C:list 18.0pt;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:Symbol;%22%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-bidi-font-family%5C:Symbol;mso-bidi-font-size%5C:10.0pt;mso-fareast-font-family%5C:Symbol;mso-list%5C:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;mso-bidi-font-family%5C:Arial;mso-bidi-font-size%5C:10.0pt;%22%3EField travel will be undertaken only when authorized and in line with WHO security, travel and duty-of-care requirements.%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22color%5C:red;font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;%22%3E%26nbsp;%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;mso-list%5C:l2 level1 lfo1;text-indent%5C:-18.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E12.%3C/strong%3E%3C/span%3E%3Cspan style=%22font%5C:7.0pt %26quot;Times New Roman%26quot;;line-height%5C:115%;mso-fareast-font-family%5C:Arial;mso-list%5C:Ignore;%22%3E%3Cstrong%3E%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22line-height%5C:115%;%22%3E%3Cstrong%3ERemuneration and budget (travel costs are excluded)%5C:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;tab-stops%5C:140.0pt;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Cspan style=%22line-height%5C:115%;mso-tab-count%5C:1;%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22MsoListParagraph%22 style=%22line-height%5C:115%;%22%3E%3Cspan style=%22font-family%5C:%26quot;Arial%26quot;,sans-serif;font-size%5C:10.0pt;%22%3E%3Ci%3E%3Cspan style=%22line-height%5C:115%;%22%3EThe duration of this consultancy is for 6 Months. Remuneration will be at applicable fees as per the World Health Organization scale of Consultant at NOC.%3C/span%3E%3C/i%3E%3C/span%3E%3C/p%3E